We have previously demonstrated that the protein encoded by the retinoblastoma susceptibility gene (Rb) functions as a regulator of transcription by RNA polymerase I (rDNA transcription) by inhibiting UBFmediated transcription. In the present study, we have examined the mechanism by which Rb represses UBFdependent rDNA transcription and determined if other Rb-like proteins have similar eects. We demonstrate that authentic or recombinant UBF and Rb interact directly and this requires a functional A/B pocket. DNase footprinting and band-shift assays demonstrated that the interaction between Rb and UBF does not inhibit the binding of UBF to DNA. However, the formation of an UBF/Rb complex does block the interaction of UBF with SL-1, as indicated by using the 48 kDa subunit as a marker for SL-1. Additional evidence is presented that another pocket protein, p130 but not p107, can be found in a complex with UBF. Interestingly, the cellular content of p130 inversely correlated with the rate of rDNA transcription in two physiological systems, and overexpression of p130 inhibited rDNA transcription. These results suggest that p130 may regulate rDNA transcription in a similar manner to Rb. Oncogene (2000) 19, 4988 ± 4999.
Introduction
Rb and Rb-like proteins have been implicated in the regulation of transcription of speci®c genes by RNA polymerase II (Qin et al., 1992; Weinberg 1995; Taya 1997) . Recent studies have extended this role, at least for Rb, to the regulation of RNA polymerase I and polymerase III transcription (Shan et al., 1992; Cavanaugh et al., 1995; White et al., 1996; Voit et al., 1997; White 1997; Hannan et al., 2000) . Rb is the 110 kDa protein product of the retinoblastoma susceptibility gene which functions as a tumor suppresser and negative growth regulator (Friend et al., 1986; Lee et al., 1987; Qin et al., 1992; Hamel et al., 1992; 1993; Levine, 1993; Claudio et al., 1994; Chen et al., 1996; White 1997; Hannan et al., 2000) . Two additional proteins have been classi®ed as Rb-like proteins, p107 and p130 (Pertile, 1995; Weinberg, 1995; Baldi et al., 1996) . All three proteins are structurally related as indicated by the presence of a typical Rb A/B pocket (Levine, 1993; Chen et al., 1996) . The A/B pocket of Rb is composed of an A domain (amino acids 379 ± 572) and B domain (amino acids 646 ± 772) separated by a spacer sequence (Knudsen and Wang, 1997; Herwig and Strauss, 1997) . The pocket binds a number of viral and cellular proteins each containing an LxCxE motif, such as UBF, hBrm, large T antigen, and E1A (Hamel et al., 1993; Copenhaver et al., 1994; Beckmann et al., 1995; Weinberg 1995; Hannan et al., 2000) . Typically, both the A and B regions of the pocket are necessary for these interactions. Thus, they are highly conserved between species and related proteins, unlike the spacer region (Knudsen and Wang, 1997) .
In addition, to sharing similar structural domains with Rb, the Rb-like proteins, p107 and p130, share some functional characteristics. For example, all three proteins can induce cell cycle arrest when over expressed in the appropriate cell line (Claudio et al., 1994) . On the other hand, dierences between these proteins have been reported. For example, p107 has not been found to be mutated in tumors or cell lines as has been reported for Rb (Levine, 1993; Claudio et al., 1994; Chen et al., 1996; LeCouter et al., 1996) and p130 (Helin et al., 1997) . Although Rb has been shown to regulate the transcription of genes transcribed by all three classes of DNA dependent RNA polymerases (Cavanaugh et al., 1995; White et al., 1996; Chu et al., 1997; Taya, 1997; White, 1997) , p130 and p107 have been shown to regulate transcription by RNA polymerases II and III (Claudio et al., 1994; Weinberg 1995; Sutclie et al., 1999.) They can also dier with respect to the proteins with which they interact. For example, E2F-1, -2, and -3 interact preferentially with Rb, E2F-4 with either p107 or p130 and E2F-5 interacts only with p130 (Moberg et al., 1996; Smith et al., 1996; Beijersbergen et al., 1994) . Although there are a number of structural and functional similarities between the members of the Rb family, they are not necessarily surrogates for one another.
In vivo and in vitro (Cavanaugh et al., 1995; Voit et al., 1997; Hannan et al., 2000) experiments have demonstrated that Rb can regulate transcription from the 45S gene promoter by RNA polymerase I (ribosomal DNA (rDNA) transcription). Several lines of evidence indicate that the eect of Rb on rDNA transcription is mediated by the interaction of Rb with the rDNA transcription factor, UBF (Upstream Binding Factor) (Cavanaugh et al., 1995; Voit et al., 1997) . UBF is a highly conserved protein which puri®es as two polypeptides, UBF1 (97 kD) and UBF2 (94 kD). These proteins are generated by alternative splicing of the transcripts of one gene (Hisatake et al., 1991; O'Mahony and Rothblum, 1991; Putnam and Pikaard, 1992; Kuhn et al., 1994; Paule, 1994) . UBF is not absolutely required for speci®c initiation on the rDNA promoter in vitro, although its addition to UBFdepleted extracts increases the eciency of transcription in a dose dependent manner (Jantzen et al., 1990; Xie et al., 1992; Smith et al., 1990; 1993) . In addition, overexpression of UBF1 in either immortal cells or primary cultures of cardiomyocytes is sucient to directly increase transcription of a reporter for rDNA transcription (Hannan et al., 1996b; . The mechanism by which UBF activates rDNA transcription requires the formation of dimers (McStay et al., 1991b; Jantzen et al., 1992; Putnam and Pikaard, 1992; Kuhn et al., 1994; Paule, 1994; Moss and Stefanovsky, 1995) , the binding of UBF to the upstream promoter element (UPE) Copenhaver et al., 1994; Paule, 1994; Moss and Stefanovsky, 1995) , and an interaction between UBF and the rDNA transcription factor SL-1 (Learned et al., 1986; Bell et al., 1988; McStay et al., 1991a; Beckmann et al., 1995; Moss and Stefanovsky, 1995; Hempel et al., 1996) . SL-1 is à basal' rDNA transcription initiation factor capable of directing multiple rounds of RNA polymerase I recruitment to the rDNA promoter. SL-1 exists as a complex containing the TATA-binding protein (TBP) and at least three RNA polymerase I speci®c TBP associated factors (TAFs) (Comai et al., 1992; Radebaugh et al., 1994) . In vitro studies suggest that the interaction between UBF and SL-1 is mediated by the SL-1 subunits, TBP and TAF 1 48 (Beckmann et al. 1995; reviewed in Moss and Stefanovsky, 1995) .
The molecular mechanism by which Rb regulates UBF-stimulated rDNA transcription is unclear. Since UBF has been shown to interact both with the rDNA promoter and SL-1, it is reasonable to hypothesize that Rb inhibits UBF-activation of rDNA transcription by disrupting one or both of these associations. The purpose of the present study was twofold; (i) to examine the mechanism by which the binding of Rb to UBF inhibits rDNA transcription; and (ii) to investigate whether Rb-like proteins might also play a role in the regulation of rDNA transcription. The results presented herein demonstrate a direct interaction between Rb and UBF via the A/B pocket of Rb. This interaction does not aect the ability of UBF to bind DNA, but instead inhibits the interaction between UBF and SL-1 (TAF 1 48). We also found the Rb-like protein, p130 but not p107, associated with UBF in vivo. Interestingly, its cellular content inversely correlated with the rate of rDNA transcription in two biological models, and the overexpression of p130 inhibited rDNA transcription as does the overexpression of Rb. These results, suggest that p130, like Rb, is a functional repressor of rDNA transcription in vivo.
Results

The interaction between Rb and UBF requires a functional A/B pocket
We (Cavanaugh et al., 1995) reported that both recombinant and authentic Rb interacted with authentic UBF and that the interaction required the A/B pocket of Rb. This was demonstrated by blocking the interaction with E7 peptide, a peptide that speci®cally binds to the A/B pocket of Rb (Beijerbergen et al., 1994) . In addition, UBF did not interact with recombinant Rb209, a naturally occurring mutant of Rb that contains an inactive A/B pocket. This mutation was ®rst described in human H209 cells, a stable cell line derived from a small cell carcinoma of the lung (Bignon et al., 1990) . In contrast, a recent publication by Voit et al. (1997) concluded that`the interaction of recombinant Rb with UBF involves the C-terminal part of Rb.' To gain a better understanding of the apparent discrepancies of these reports, we reexamined the requirement for the Rb pocket in mediating the Rb-UBF interaction.
Both our experiments and those of Voit et al. (1997) utilized recombinant pocket proteins. In some cases recombinant proteins may be modi®ed by proteolytic cleavage and subsequently not fold correctly when expressed in E. coli. Moreover, Rb is highly susceptible to inactivation during puri®cation. For example, exposure of Rb to the protease inhibitor PMSF can both inhibit its binding to bone ®de target proteins and, in some cases, promote the promiscuous binding to other proteins (Dr P Hamel, personal communication) . To establish a baseline for the present experiments, some of which use recombinant protein, we compared the abilities of authentic Rb (present in rat NISI cells) and authentic Rb 209 (present in human H209 cells) to interact with UBF ( Figure 1a ). Extracts from either H209 or N1S1 cells were subject to immunoprecipitation with either anti-UBF or anti-Rb antibodies. The immunoprecipitates were then analysed by Western blotting using anti-UBF and anti-Rb antibodies. Anti-UBF immunoprecipitated Rb from the N1S1 extracts, but not from the H209 cell extracts (Figure 1a , compare lanes 3 and 4, lower panel). The complementary immunoprecipitation with anti-Rb antibodies did not bring down UBF from the H209 cells, whereas UBF did coimmunoprecipitate with Rb from the N1S1 cell extracts (Figure 1a , compare lanes 5 and 6, upper panel). (n.b. human Rb is slightly larger than rodent Rb and migrates more slowly in SDS ± PAGE) These observations demonstrate that the interaction between UBF and Rb requires a functional A/B pocket, con®rming the original observation reported by Cavanaugh et al. (1995) .
We then characterized the recombinant fusion proteins GST-Rb and GST-Rb209 used in our studies by analysing their ability to associate with large T antigen, which speci®cally interacts with the A/B pocket of Rb (Bignon et al., 1990; Hensel et al., 1990; Hamel et al., 1993; Weinberg, 1995; Taya, 1997) . Extracts from COS-7 cells, which express both UBF and large T antigen, were incubated with either GST-Rb or GST-Rb209 immobilized on GSH-Sepharose beads. The beads were washed in binding buer, the bound proteins were eluted with glutathione, fractionated by SDS ± PAGE, and transferred to Immobilon-P. When the blot was probed with antibodies to large T antigen and UBF, we observed that both proteins had bound to GST-Rb but not GST-Rb209 (Figure 1b ). These results demonstrate that the GST-Rb used in our experiments has a functional A/B pocket, and that both the recombinant Rb and recombinant Rb209 had characteristics similar to those reported previously (Bignon et al., 1990; Hensel et al., 1990; Kaye et al., 1990) . Again, these results are consistent with the conclusion that sequences within the A/B pocket of Rb are critical for the association of Rb with UBF.
UBF and Rb interact directly
The results described above demonstrate an interaction between UBF and Rb using cell extracts and implicate a role for the A/B pocket of Rb in this interaction. However, these results do not discriminate between the possibilities that UBF and Rb interact directly or via one or more bridging proteins. To address this question, we examined the interactions between puri®ed recombinant: UBF1 (expressed in Sf9 cells: bvUBF1) and various puri®ed, recombinant Rb constructs (Figure 2a) .
Puri®ed bvUBF1 was incubated with recombinant Rb, Rb209, and the C-terminal domain of Rb and the resulting complexes immunoprecipitated with anti-UBF antibodies. Rb coimmunoprecipitated with UBF, but neither Rb209 nor the C-terminal fragment of Rb did (Figure 2b , lanes 6 ± 8, respectively). Similar results were obtained when the reverse experiment was done. Puri®ed bvUBF1 was incubated with either GSTRb or GSTRb209 immobilized on GSH-Sepharose, or GSHSepharose beads alone. The beads were washed, and the bound proteins were eluted with glutathione as described in Material and methods. Figure 2c , panel A illustrates that bvUBF1 binds to GST-Rb (lane 2) but not to GST-Rb209 (lane 3) or GSH-Sepharose beads alone (lane 4). These results demonstrate that UBF interacts directly with Rb in vitro, that the C-terminal fragment of Rb is not sucient to support an interaction between UBF and Rb, and again con®rm the requirement for a functional A/B pocket.
Rb does not disrupt the interaction between UBF and DNA
The molecular mechanism by which Rb regulates UBF-stimulated rDNA transcription is unclear. As mentioned above, UBF must interact with both the rDNA promoter and SL-1 in order to activate transcription. Thus, Rb can inhibit UBF activation of rDNA transcription by disrupting either or both of these associations. To distinguish between these possibilities, the eect of Rb on UBF binding to DNA was assessed by examining its ability to disrupt: (i) a UBF DNase footprint; or (ii) the binding of UBF to cruciform DNA in an EMSA.
UBF footprinting was carried out using a BamHI ± HindIII fragment of the rat rDNA promoter (7286 to +124) labeled at 7286. Incubation of the rDNA fragment with authentic, rat UBF and DNase I resulted in a protection pattern (Figure 3 , compare lanes 1 and 4) identical to those we and others have reported (Pikaard et al., 1990; Smith et al., 1990) . The addition of a fourfold excess of puri®ed GST-Rb had no aect on the UBF footprint (Figure 3 , compare lanes 1 and 2). A control digestion demonstrated that Rb alone did not signi®cantly alter the DNase protection pattern (Figure 3, compare lanes 3 and 4) . These results suggest that the binding of Rb to UBF does not alter the UBF footprint.
Even though Rb was present in excess in the footprinting assays, there was still the possibility that the footprints were due to free UBF and not the result of UBF that was complexed with Rb. To examine this possibility, we carried out band-shift assays using labeled cruciform DNA (Crx), and puri®ed recombi- Whole cell extracts of H209 or N1S1 cells were tumbled for 2 h with anti-UBF (lanes 3 and 4) or anti-Rb (lanes 5 and 6) antibodies bound to protein-A agarose beads. The beads were washed and bound proteins fractionated by SDS ± PAGE, transferred to Immobilon-P, and incubated with anti-UBF (upper panel) or anti-Rb (lower panel) antibodies. Immunoreactive proteins were visualized by ECL. Note: the molecular mass of human Rb is greater than that of rat Rb. (b) GSTRb, but not GSTRb209, interacts with T Antigen and UBF. Whole cell extracts of COS-7 cells were tumbled for 2 h with GSTRb or GSTRb209 bound to GSH beads, in the presence of 0.5% NP-40. The beads were washed and bound proteins were eluted with 50 mM glutathione. The eluted proteins were fractionated by SDS ± PAGE, transferred to Immobilon-P, and incubated with anti-T Antigen (upper panel) or anti-UBF (lower panel) antibody. Immunoreactive proteins were visualized by ECL nant UBF and Rb. In these experiments, a UBF-RbCrx complex would be expected to result in a supershift when compared to the mobility of a UBFCrx complex. As shown in Figure 4 (lane 1) incubation of UBF with cruciform DNA resulted in formation of a UBF-DNA complex (UBF-Crx) which was competed by the addition of a 50-fold excess of cold cruciform DNA ( Figure 4 , lane 2). We then determined the eect of adding Rb on the formation of the UBF-DNA complex. The addition of a fourfold or eightfold excess of GST-Rb (sucient to block the ability of UBF to activate transcription) to the binding assays containing UBF resulted in the formation of a second, more slowly moving DNA-protein complex (Figure 4 , lanes 3 and 4; Rb-UBF-Crx). When the ratio of Rb to UBF was increased to 32 : 1 (an amount of Rb signi®cantly in excess of that required to inhibit the ability of UBF to activate rDNA transcription (Cavanaugh et al., 1995) ), the amounts of both the Rb-UBF-Crx complex and the UBF-Crx complex decreased ( Figure 4 , lane 5). It should be noted that Rb alone (the same amount as that present in Figure 4 , lane 4) did not form a detectable DNA complex in these assays (lane 6), and the Rb-UBF-Crx complex could also be competed with an excess of cold cruciform DNA (lane 7). These results suggest that when UBF is complexed with Rb it can still bind DNA. In addition, they suggest that secondary, probably nonspeci®c, interactions occur at high Rb:UBF or Rb:DNA ratios, and that these interactions interfere with the formation of a UBF-DNA complex. When the DNase footprinting and EMSA experiments are considered cumulatively, they demonstrate that UBF complexed with Rb can still bind DNA.
Rb disrupts the interaction between UBF and SL-1
SL-1 is a complex comprised of TATA binding protein (TBP) and at least three TBP associated factors which are speci®c for rDNA transcription, TAF 1 110, TAF 1 63, and TAF 1 48 (Comai et al., 1994) . Hempel et al. (1996) reported that SL-1 can be co-immunoprecipitated with UBF, indicating that the two factors interact in solution. Additional studies using recombinant SL-1 subunits demonstrated that UBF interacts with TBP and the 48 kDa subunit of SL-1, TAF 1 48 (Comai et al., 1994; Beckmann et al., 1995) . Since Rb did not interfere with DNA-binding, we considered the possibility that Rb might disrupt the interaction between UBF and SL-1.
This possibility was tested in two dierent experiments. In the ®rst, we examined whether the addition of Rb or Rb209 would inhibit the co-immunoprecipitation of UBF and SL-1 in cell extracts. Immunopreci- Figure 2 (a) Coommassie staining of the recombinant puri®ed proteins. Equal amounts (10 mg) of GSTRb, GST, bvUBF1, GSTRb209 and GSTRb C-term were fractionated by SDS ± PAGE and stained with Coommassie blue. The gel was dried and scanned using a laser densitometer. (b) Recombinant bvUBF coimmunoprecipitates Rb but not Rb209 or Rb C-term. GSTRb, GSTRb209, or GSTRb C-term were tumbled for 2 h with bvUBF, and the UBF was immunoprecipitated with anti-UBF bound to protein A Sepharose. The bound proteins were fractionated by SDS ± PAGE, transferred to Immobilon-P, and probed with an anti-UBF (upper panel) or anti-GST (lower panel) antibodies. Immunoreactive proteins were visualized by ECL. (c) Recombinant GSTRb, but not GSTRb209, coimmunoprecipitates bvUBF1. Recombinant bvUBF1 was tumbled for 2 h with GSTRb (lane 2). GSTRb209 (lane 3) bound to GSH beads or GSH beads alone (lane 4). The beads were then washed and bound proteins were eluted with 50 mM glutathionine. The eluted proteins were fractionated by SDS ± PAGE, transferred to Immobilon-P, and probed with an anti-UBF (a) or anti-Rb (b) antibodies. Immunoreactive proteins were visualized by ECL pitation experiments were carried out essentially as described previously (Hempel et al., 1996) using the same UBF antiserum and a preimmune serum. We found that the addition of GST-Rb signi®cantly reduced the amount of SL-1 in the anti-UBF immunoprecipitate and that the addition of GSTRb209 had no aect on the amount of SL-1 in the immunoprecipitate. Further, GST-Rb was found in the immunoprecipitate and GST-Rb209 was not (data not shown).
Since Rb disrupted the interaction between authentic UBF and SL-1, we next examined whether this could be demonstrated using recombinant proteins. Speci®cally, the experiment was designed to determine if Rb could disrupt the association between UBF and TAF 1 48, since this is a subunit speci®c for SL-1, unlike TBP. Puri®ed bvUBF1 was incubated with bvTAF 1 48-FLAG immobilized on anti-FLAG beads.
After the resin was washed, the bound proteins were eluted with FLAG peptide, fractionated by SDS ± PAGE and transferred to Immobilon-P. Probing the ®lter with anti-UBF antibodies ( Figure 5 ) demonstrated that bvTAF 1 48-FLAG bound bvUBF1 (lane 1). FLAG beads in the absence of bvTAF 1 48-FLAG did not bind UBF (data not shown). The addition of recombinant Rb to a binding reaction prevented the association of UBF with immobilized bvTAF 1 48-FLAG, as evidenced by the signi®cant decrease in the amount of UBF1 that bound to and could be eluted from the bvTAF 1 48-FLAG resin ( Figure 5 , compare lanes 1 and 2). Probing of the same ®lter with anti-Rb antibodies demonstrated that Rb did not bind to immobilized bvTAF 1 48-FLAG (data not shown). Figure 5 Rb blocks the interaction of UBF with the 48 kDa subunit of SL-1 (TAF 1 48). Puri®ed, recombinant bvUBF1 was tumbled for 2 h with FLAG tagged TAF 1 48 immobilized on FLAG resin alone (lane 1), or in the presence of either GSTRb (lane 2), GSTRb and 100 mg E7 (lane 3), or GSTRb and 100 mg E7* (lane 4). The beads were then washed and bound proteins eluted with FLAG peptide. The eluted proteins were fractionated by SDS ± PAGE and transferred to Immobilon-P. The blots were incubated with anti-UBF antibody and immunoreactive proteins were visualized by ECI Figure 3 Rb does not aect the UBF footprint on the rDNA promoter. Recombinant UBF1 alone (lane 1), recombinant UBF plus recombinant GST-Rb (lane 2), or recombinant GSTRb alone (lane 3) were incubated with the BamHI-HindIII fragment of the rat rDNA promoter and DNase I as described in Materials and methods. The products of the footprinting reactions were electrophoresed in parallel with a DNase digestion of the fragment alone (lane 4). The region protected in a typical DNase I digestion, the UPE, is indicated by the solid bar Figure 4 Rb causes the UBF-DNA complex to supershift. Puri®ed UBF was incubated with cruciform DNA as described (Copenhaver et al., 1994) , resulting in a band-shift (UBF-Crx., lane 1) which could be competed by the addition of 50-fold excess cold cruciform DNA (lane 2). The addition of increasing amounts of GSTRb (lanes 3 and 4) resulted in a supershift, or the inhibition of DNA-binding by UBF (lane 6). The molar ratios of Rb to UBF were 4, 8, and 32, respectively. GSTRb alone did not bind to cruciform DNA (lanes 6 and 7). The binding reactions in lanes 6 and 7 contained the same amount of Rb as that in lane 4
In order to determine the speci®city of the eect of Rb on the interaction between UBF and TAF 1 48, and the role of the A/B pocket of Rb in this interaction, E7 or E7* peptide (see Materials and methods) was added to some reactions. The presence of an excess of E7 peptide in a binding assay should eectively sequester Rb. This would free up the UBF in that assay, if the Rb-UBF interaction is mediated by the A/B pocket, allowing it to bind to the immobilized bvTAF 1 48. As predicted by the model in which the interaction between UBF and Rb is mediated by the A/B pocket, the addition of E7 peptide abolished the ability of Rb to prevent the association of UBF with the bvTAF 1 48-FLAG resin ( Figure 5 ). This is demonstrated by the increase in the amount of UBF1 in the FLAG eluate when E7 was added to the binding reaction ( Figure 5 , compare lanes 2 and 3). In contrast, the addition of E7* did not result in an increase in the amount of UBF1 in the FLAG eluate ( Figure 5, compare lanes 3  and 4) . These results clearly demonstrate that the speci®c interaction between Rb and UBF requires the A/B pocket and prevents the formation of a UBF/ TAF 1 48 complex.
The Rb-like protein p130 but not p107 interacts with UBF p130 and p107 are Rb-like proteins that share some structural and functional properties with Rb (Levine, 1993; Claudio et al., 1994; Chen et al., 1996; LeCouter et al., 1996) . Since Rb has been shown to be a regulator of rDNA transcription, it is possible that p130 and p107 may play similar roles. To investigate this possibility, we ®rst examined if p130 and p107, like Rb, could be coimmunoprecipitated with the rDNA transcription factor UBF.
We tested this possibility by performing immunoprecipitation studies using nuclear extracts of N1S1 cells. The extracts were subject to immunoprecipitation with either p130 or p107 antibodies as described in Materials and methods. After the beads were washed, the immunoprecipitated proteins were fractionated by SDS ± PAGE and transferred to Immobilon-P. Western analysis (Figure 6 ) demonstrated that UBF coimmunoprecipitated with p130 (lane 2) but not with p107 (lane 3). Analysis of the supernatants demonstrated that the antibodies had precipitated at least 80% of the input p107 and p130 (Figure 6, lanes 4 and 5,  respectively) . Similar results were obtained with H209 cell extracts (data not shown). These results demonstrate that p130 and UBF can be found in the same complex, and that UBF does not interact signi®cantly with the third pocket protein, p107. The latter result is in agreement with the ®nding of Voit et al. (1997) . Our observation that p130, like Rb, interacts with UBF suggests that this association might contribute to the regulation of rDNA transcription in vivo. This led us to search for evidence in support of that hypothesis.
p130 cellular content inversely correlates with the rate of rDNA transcription
We have previously reported that as NIH3T6 cells become con¯uent, the rate of rDNA transcription decreases and the cellular content of hypophosphorylated Rb increases (Hannan et al., 2000) . As our model would also predict an inverse correlation between the cellular content of p130 and rDNA transcription, we measured the content of p130 in NIH3T6 cells as their population expanded in culture and rDNA transcription decreased. As shown in Figure 7 , the relative content of p130 increased as cell density increased.
Further evidence for this model was obtained in a second biological system. When, serum starved NIH3T6 cells are treated with insulin or when exponentially growing H4-II-E-C3 cells are treated with insulin, the rate of rDNA transcription increases (Hannan et al., 1998) . The results shown in Figure 8a demonstrate that when NIH3T6 cells that had been serum starved for 72 h Figure 7 The cellular content of p130 increases with cell cycle arrest and reduced rDNA transcription. Nuclei were isolated from NIH3T6 cells harvested at the percentage con¯uence indicated. Nuclear proteins were fractionated by SDS ± PAGE, transferred to Immobilon-P, and incubated with anti-p130 antibody. The immunoreactive proteins were visualized by ECL. Equal amounts of protein (1.2 mg) were loaded per lane. The results are expressed relative to control, i.e., the signal obtained from extracts of cells at 100% con¯uence. Each bar represents the mean+s.d. (n=3) Figure 6 UBF coimmunoprecipitates with p130 but not p107. A nuclear extract of N1S1 cells was incubated with either anti-p130 or anti-p107 antibodies and protein-A Sepharose. The immunoprecipitates were collected, washed, boiled in 26Laemmli sample buer, fractionated by SDS ± PAGE, and transferred to Immobilon-P. After UBF was detected with anti-UBF antiserum and ECL the ®lter was stripped, and p130 and p107 were detected with anti-p130 and p107 antibodies, respectively. The`load' (lane 1) represents 5% of the input protein and the supernatants (Super., lanes 4 and 5) contained approximately 10% of the unbound material before any washes were refed serum or treated with insulin the content of p130 signi®cantly decreased (Figure 8a) . Similarly, when insulin was added to the medium of exponentially growing H4-II-E-C3 cells the content of p130 signi®-cantly decreased (Figure 8b ). It is also interesting to note that there is a dierence in protein content of p130 between exponentially growing H4-II-E-C3 and NIH3T6 cells suggesting cell type regulation. The inverse correlation between rDNA transcription and the cellular content of p130 provided correlative evidence for the hypothesis that that p130 might be involved in the regulation of ribosome biogenesis in vivo.
Overexpression of p130 blocks the UBF-dependent activation of rDNA transcription
We tested this hypothesis by determining if the overexpression of p130 would be sucient to inhibit rDNA transcription in vivo using a reporter for rDNA transcription, pSMECAT (Hannan et al., 1996b; .
As shown in Figure 9a , cotransfection of 3T6 cells with the UBF1 expression vector (pCDNA3UBF1) and the rDNA reporter, pSMECAT, resulted in stimulated rDNA transcription compared to cells transfected with pSMECAT alone (compare lanes 2 and 3) or the negative control pSMECAT-7 (lane 1). When 3T6 cells were cotransfected with pSMECAT, pCDNA3UBF1, and increasing amounts of pCMVp130 (to drive p130 expression), the UBF-dependent activation of rDNA transcription was inhibited in a dose dependent manner (Figure 9a , lanes 4 ± 6; depicted graphically in (b), in parallel with the increase in p130 (Figure 9c ). These results demonstrate that overexpression of p130, similar to Rb, blocks UBF-dependent activation of rDNA transcription.
Discussion
Previous studies have demonstrated an inverse correlation between the presence of Rb-UBF complexes in Figure 9 p130 inhibits the UBF-dependent activation of rDNA transcription. (a) CAT assays were performed from extracts of 3T6 cells 24 h after transfection. The cells were transfected with pSMECAT-7 (1 mg) or pSMECAT (1 mg). When indicated (+) the cells were cotransfected with 1 mg of pCDNA3UBF1 and/or 0.5, 1.0, or 2 mg of pCMVp130. All transfections were performed using lipofectamine, a constant DNA concentration (5 mg) and included pCMV-bGal (1 mg) as an internal standard for the eciency of transfection as described in Materials and methods. vivo and the rate of rDNA transcription (Cavanaugh et al., 1995; Hannan et al., 2000) . Such studies support a model for the regulation of rDNA transcription whereby the activity of UBF is repressed by sequestration into Rb/-UBF complexes, thus reducing the rate of UBF-dependent transcription of the rRNA genes (Cavanaugh et al., 1995; Voit et al., 1997; Hannan et al., 2000) . However, those studies either contradicted each other, for example with respect to the domains involved in the interaction, or did not address the molecular mechanism(s) by which this inhibition occurs. This study ®rst sort to clarify the domain of Rb involved in the interaction with UBF and then examine the mechanism(s) by which this interaction inhibited rDNA transcription.
Rb and UBF interact via the A/B pocket
Our laboratory was the ®rst to demonstrate that anti-UBF antibodies co-immunoprecipitated Rb from nuclear extracts of dierentiated U937 cells via the A/B pocket (Cavanaugh et al., 1995) . However, Voit et al. (1997) suggested that this interaction was in fact mediated by the C-terminal region of Rb. In light of these con¯icting results we examined this interaction using authentie UBF, Rb and Rb209 (Rb with a nonfunctional A/B pocket). We demonstrated using these endogenous proteins that UBF interacted with Rb but not Rb209. Clearly these results con®rmed our previous observation that the interaction between UBF and Rb occurs via the A/B pocket in a biological setting, as demonstrated by the results obtained using H209 cells (Figure 1a) . This was further substantiated by repeating the interaction using puri®ed recombinant proteins.
In light of our results, it is important to reexamine those of Voit et al. (1997) , with the caveat that there may be technical reasons for the discrepancies between their observations and our own. They concluded that the C-terminal region of Rb, rather than the A/B pocket, mediated the interaction with UBF. This conclusion was deduced from three observations: (i) the Rb-like protein, p107, which has an A/B pocket, did not inhibit rDNA transcription; (ii) the addition of E7 peptide or generation of a point mutation in one UBF LxCxE did not aect Rb-mediated repression of rDNA transcription; and (iii) Rb209, but not Rb minus the C-terminal region (amino acids 792 ± 928) inhibited rDNA transcription and coimmunopreciptated with UBF. p107 may not be the most suitable control for Rb A/ B pocket. For example, even though p107 and Rb have a 62% amino acid identity they do not share all the same functional or structural characteristics (Weinberg 1995; Taya 1997) . For example Rb, p107 and p130 have dierent binding preferences to the E2F family members via the A/B pocket (Beijersbergen et al., 1994; Claudio et al., 1994; Moberg et al., 1996; Smith et al., 1996) . Also a small change in amino acid sequence can signi®cantly change the characteristics of the A/B pocket as demonstrated by the one amino acid substitution found in Rb209 (Bignon et al., 1990; Hensel et al., 1990; Kaye et al., 1990) . Thus, it is possible that the amino acid sequences of p107 and Rb dier in the region(s) critical for the interaction with UBF. In fact we demonstrated that in coimmunoprecipitation studies using NISI cell extracts that UBF bound Rb and p130 but not p107 (Figure 6) . Voit et al. (1997) concluded that as the E7 peptide did not inhibit the UBF-Rb interaction, this interaction was not mediated by the A/B pocket of Rb. Since this peptide mimics only part of the domain of E7 protein that interacts with Rb a high concentration must be used in these competition experiments (Cavanaugh et al., 1995 and references therein) . The highest concentrations of E7 peptide used by Voit et al. (1997) were considerably lower than those recommended (see Cavanaugh et al., 1995) . Voit et al. (1997) also demonstrated that Rb could inhibit UBF-dependent transcription even if UBF had a E311Q point mutation in one LxCxE (the putative Rb binding domain in HMG box 3). Interestingly, analysis of the UBF sequence demonstrates the presence of several putative Rb binding domains, and preliminary studies in our laboratory and others (Dr Tom Moss, personal communication), indicate that other domains of UBF can interact with Rb. It is therefore possible that any or all of these LxCxE consensus sequences might contribute to the Rb-UBF interaction. Thus, a mutation in one domain might not be sucient to eliminate binding to Rb.
We did not focus on a potential role for the Cterminal domain of Rb in the interaction with UBF. Our results, led us to focus on the A/B pocket, and clearly demonstrate a central role for this portion of the molecule in mediating the interaction with UBF. Moreover, in our hands, the C-terminal portion of Rb did not coimmunoprecipitate with UBF. However, it is possible that a portion of the interaction between UBF and Rb is mediated through the C-terminus of Rb. Be that as it may, one could argue that the results obtained with Rb209 are of greater biological interest as that mutation has been identi®ed in a physiological setting, such as small cell lung carcinoma, and the entire exon 21 is deleted in a number of cancers (exon 21 contains the site of the Rb209 mutation; Farshid et al., 1994; Liu et al., 1994) .
Rb and UBF interact directly
While we have reported coimmunoprecipitation of UBF and Rb in a number of systems (Cavanaugh et al., 1995; Hannan et al., 2000) these studies did not demonstrate whether the two proteins interacted directly or via bridging protein(s). The results described here strongly suggest that UBF can interact directly with Rb, in the absence of accessory proteins, since puri®ed recombinant UBF1 was selectively retained on a GSTRb anity column but not on a GSTRb209 column or control GSH beads.
Rb does not disrupt DNA-binding by UBF, but inhibits the interaction between UBF and SL-1 UBF needs to interact with both the rDNA promoter and SL-1 in order to enhance rDNA transcription (Jantzen et al., 1992; Paule, 1994 and references therein). Thus, we hypothesized that Rb may repress UBF-mediated activation of rDNA transcription by disrupting one or both of these interactions. The present study demonstrates by footprinting analysis and EMSA that Rb, at a concentration which can inhibit in vitro rDNA transcription, does not aect the ability of UBF to bind DNA. However, when the molar ratio of Rb to UBF is raised to very high levels (32 : 1), as in the EMSA experiments, the ability of UBF to bind DNA does become compromised. While this result is similar, at least in part, to that reported by Voit et al. (1997) , there is a signi®cant dierence. In their footprinting assays, Rb blocked the ability of UBF to bind to DNA at a molar ratio of *15 : 1. However, they found that a molar ratio of Rb:UBF of *1 : 4 (Voit et al., 1997; legend to Figure 7 ) was sucient to inhibit binding in an electrophoretic mobility shift assay.
Our data demonstrated that Rb disrupted the interaction between UBF and SL-1 in cell extracts as well as the interaction between recombinant UBF and the 48 kDa subunit of SL-1. TAF 1 48 was used instead of TBP since it is speci®c for SL-1 whereas TBP is also found in TFIID and TFIIIB.
The Rb-like protein, p130 mimics Rb inhibition of rDNA transcription
As mentioned in the introduction, two Rb-like proteins have been identi®ed, p130 and p107. This raises the possibility that Rb-like proteins may mimic Rb inhibition of rDNA transcription. We examined this possibility in vivo and demonstrated that signi®cant amounts of UBF could be coimmunoprecipitated with p130, but not p107, from NISI and H209 cells. We also demonstrated an inverse correlation between p130 cellular content and rate of rDNA transcription in two systems: (i) cell cycle arrest by contact inhibition of NIH3T6 cells elevated p130 and Rb cellular content and reduced rDNA transcription; (ii) insulin-mediated stimulation of rDNA transcription dramatically decreased p130 cellular content in both serum-starved NIH3T6 cells and exponentially growing H4-II-E-C3 cells. Interestingly, when H4-II-E-C3 cells were treated with insulin, the cellular content of p130 changed but Rb levels were not altered (Hannan and Rothblum, unpublished observation) . This suggests that the regulation of rDNA transcription by p130 and Rb can occur via separate and independent pathways. These results plus the coimmunoprecipitation data suggests that p130 may mimic Rb and inhibit rDNA transcription. The ®nal experiment demonstrated that in fact overexpression of recombinant p130 can repress UBF-mediated rDNA transcription in vivo.
These ®ndings are interesting since Rb, p130 and p107 all have homologous A/B pockets. However, as mentioned previously, there is a precedence for dierential interactions between the A/B pockets of Rb, p130 and p107 and target proteins. For example E2F-1, -2 and -3 interact preferentially with Rb, E2F-4 with either p107 (in S phase) or p130 (in G1 phase) and E2F-5 interacts with p130 only (Taya 1997; Moberg et al., 1996; Smith et al., 1996; Beijersbergen et al., 1994; Richon et al., 1997) . Thus, by analogy these Rb pocket proteins may interact dierentially with UBF. We cannot however completely rule out an interaction between UBF and p107. The phosphorylation state of Rb and the Rb-like proteins has also been shown to regulate their ability to bind other proteins. For example the interaction of p107, via the A/B pocket, with E2F-4 or HDAC1 can be prevented by phosphorylation of p107 (Ferreira 1998) . In light of these results it is possible that the phosphorylation state of p107 in the NISI or H209 cell extracts may have prevented an interaction between p107 and UBF. We were unable to determine the phosphorylation state of p107 in those experiments as antibodies which can discriminate between phosphorylated or unphosphorylated p107 were unavailable. Even so, our results correlate well with the observation that high levels of active p130 are typically found in quiescent cells (when we see an association of p130 with UBF) while p107 is predominate in growing cells (Smith et al., 1998) . Thus, in exponentially growing cells, which have a high level of active p107, it would be counter productive for p107 to interact with UBF and reduce rDNA transcription. These studies further emphasize the similarities and dierences in the functions of the Rb-like proteins in regulating growth and cell cycle progression.
Our results con®rm that the content of p130 is regulated in a cell type dependent manner. A number of studies have demonstrated the ubiquitous expression of p130, but dierences in its tissue distribution and/or levels of expression in various organs (Baldi et al., 1997; Helin et al., 1997) . Cell type dependent expression adds to the complexity of p130 regulation and ultimately to that for rDNA transcription.
In summary, the present study supports the model that Rb inhibits UBF-dependent rDNA transcription by binding directly to UBF, and that the UBF-Rb complex can no longer interact with SL-1 and activate rDNA transcription. In addition our data suggest that there is functional redundancy to this pathway of regulating rDNA transcription, in that a second pocket protein, p130 can also act to inhibit UBF-dependent rDNA transcription.
Materials and methods
Cell culture
Monolayer cultures of COS-7 cells (ATCC CRL 1651) and NIH3T6 cells (ATCC CCL96) were maintained in Dulbecco's modi®ed Eagle's medium (DMEM, GIBCO) supplemented with 10% fetal bovine serum (FBS) at 378C in a 5% CO 2 atmosphere. N1S1 cells (ATCC CRL 1604) were maintained in RPMI 1640 (Mediatech) supplemented with 5% FBS in spinner¯asks at 378C in a 5% CO 2 atmosphere. NCI-H209 cells (ATCC NTB 172) were maintained in RPMI 1640 supplemented with 5% newborn calf serum (NCS) and 5% horse serum. Sf9 cells (ATCC CRL 1711) were maintained in spinner¯asks at 278C in normal atmosphere in Graces medium supplemented with 2 mM glutamine, 20 mg gentamicin, 1% Pluronic 68 and 10% FBS. H4-II-E-C3 cells (ATCC CRL-1600) were maintained in DMEM, supplemented with 5% FBS, 5% NCS, 0.05% NaHCO 3 and 63 mM HEPES (pH 7.3), at 378C in a 5% CO 2 atmosphere.
Cell confluence-induced cell cycle arrest
Monolayer cultures of NIH3T6 cells were plated on 100620 mm tissue culture dishes at 0.25610 6 cells/dish and the medium changed every 2 days. Cells were harvested at 24 h intervals for up to 144 h as described in Hannan et al. (2000) . Whole cell and/or nuclei extracts were prepared.
Insulin treatment
Monolayer cultures of NIH3T6 cells were plated as above and after 24 h of culture, the medium was replaced with DMEM containing 0.5% FBS. Following an additional 72 h (serum-starved), the medium was replaced with DMEM containing 10% FBS (serum), or human recombinant insulin was added directly to the medium to a ®nal concentration of 10 nM. Cells were harvested at 3, 6, 12, and 24 h after treatment as described in Hannan et al. (1998) . Exponentially growing cells were plated at 6.25610 4 cells/dish and were maintained in DMEM containing 10% FBS ensuring that when harvested, the cell density was equivalent to that of the serum-starved cells. Monolayer cultures of H4-II-E-C3 cells were plated on 100 mm tissue culture dishes at 1610 6 cells/dish. After 24 h, human recombinant insulin was added directly to the medium to a ®nal concentration of 10 nM. Cells were harvested at 3, 6, 12 and 24 h after treatment as described in Hannan et al. (1998) . Whole cell and/or nuclei extracts were prepared.
Whole cell and nuclei extracts
Approximately 2610 6 cells were released from the plates after treatment with 0.25% trypsin-EDTA or collected by centrifugation at 1000 g for 5 min. For whole cell extracts the cell pellets were washed once with ice-cold PBS, resuspended in 1 ml of EBC buer (50 mM Tris HCl, pH 8.0, 120 mM NaCl, 0.5% NP40, 100 ml/ml aprotinin, 100 mM benzamidine, 10 mM leupeptin), and incubated on ice for 20 min. The cells were broken by mixing with a vortex, the homogenate was clari®ed by centrifugation (10 000 g for 15 min), and the supernatant was stored at 7808C. For nuclei extracts the cell pellet was resuspended while vortexing in 4 ml of nuclear isolation buer (10 mM Tris, pH 7.4, 10 mM NaCl, 10 mM MgCl 2 , 0.5% NP-40) and incubated on ice for 10 min. Nuclei from the lysed cells were collected by centrifugation (400 g, 5 min) and the pellet resuspended in 200 ml of nuclear storage buer (50 mM Tris, pH 8.3, 40% glycerol, 5 mM MgCl 2 , 0.1 mM EDTA). A 20 ml aliquot was removed for DNA quanti®cation (Cersarone et al., 1979) and the remainder aliquoted, frozen in a dry ice/ethanol bath, and stored at 7808C.
Western blot analysis
Samples were diluted in 26Laemmli sample buer, heated at 958C for 10 min, electrophoresed on 10% SDS ± PAGE, and then electroblotted onto Immobilon-P membranes (Millipore). Western blotting was carried out as described (Hannan et al., 1996a) . Antigen-antibody complexes were visualized by the Enhanced Chemiluminescent (ECL) method (Amersham), and quantitated by laser densitometry (Molecular Dynamics). Molecular sizes were veri®ed by comparison to the migration of standard protein markers (Bio-Rad).
Monoclonal anti-human retinoblastoma protein was obtained from PharMingen (California: Cat# 14001). Polyclonal anti-p130 (Cat# sc-317), monoclonal anti-TBP (Cat# sc-421) and monoclonal p107 (Cat# sc-318) were obtained from Santa Cruz (California). Polyclonal rabbit antiserum to UBF was used as described previously (Hannan et al., 1996a) . Polyclonal rabbit antiserum to T-Antigen was kindly supplied by Dr. Brian Kennedy, Polyclonal anti-GST (Cat# G-7781) was obtained from Sigma.
GST fusion proteins
All the GST constructs used were based on pGEX-2T. GSTRb contains amino acids 394 ± 928 of Rb inserted downstream of the glutathione S-transferase gene (Kaye et al., 1990) . GSTRb209 contains amino acids 394 ± 928 of the mutant form of Rb, Rb209, identi®ed in H209 cells. Rb209 is identical to the wild-type Rb except for a single amino acid substitution of a phenylalanine at residue 706 for a cysteine (Bignon et al., 1990; Kaye et al., 1990) . This substitution generates an inactive A/B pocket (Bignon et al., 1990) . GSTRb C-term contains amino acids 792 ± 928 of Rb. All GST constructs were expressed in BL21pLysS according to the suppliers directions. After 3 ± 6 h, the cells (500 ml culture) were pelleted by centrifugation (1000 g, 15 min) and resuspended in 5 ml of FPLB buer (500 mM NaCl, 1% Triton X100, 50 mM HEPES, 2 mM EDTA, 10% glycerol, 100 ml/ml aprotinin, 100 mM benzamidine, 10 mM leupeptin) and then sonicated for three 30 s bursts. The sonicated samples were centrifuged (8000 g, 10 min), and the chimeric protein was puri®ed by anity chromatography of the supernatant on GSH-Sepharose. The extracts (5 ml) were tumbled with 100 ml of washed GSH-Sepharose (glutathione-Sepharose 4B: Pharmacia) beads for 2 h at 48C. The beads were pelleted by centrifugation (8000 g, 30 s), washed once with 1 ml of PBS containing 0.5 M NaCl and washed twice with 1 ml of FPLB. The GST bound proteins were eluted by incubating 20 ml of the beads with 25 ml of 50 mM glutathione, dissolved in 100 mM Tris pH 8.3, for 20 min on ice. The beads were pelleted and the supernatant was retained. The elution step was repeated and the two supernatants pooled. The pure protein was stored at 7808C. The quality of the puri®ed proteins is illustrated by the coommassie staining of an SDS ± PAGE in Figure 2a .
Co-immunoprecipitation using affinity purified antibodies
All steps of the co-precipitation experiments were performed at 48C. Whole cell or nuclear extracts (1.5 mg of protein) were pre-cleared by incubating for 30 min with protein Aagarose beads (prewashed with buer C/10 plus 0.02% NP-40; Sigma) while gently tumbling. The beads were removed by centrifugation for 5 s, and the pre-cleared extracts were incubated with 1 mg of either monoclonal anti-Rb, polyclonal anti-UBF (Hannan et al., 1996a) , polyclonal antip130 or monoclonal anti-p107 antibodies. Alternatively puri®ed proteins such as bvUBF, GSTRb, GSTRb209, GSTRb C-term were mixed and incubated with 1 mg of the required antibody. NP-40 was added to a ®nal concentration of 0.5%, and the samples tumbled for 2 h. To the sample 25 ml (packed volume) of washed protein Aagarose beads were added and then tumbled for an additional 2 h. The beads were washed three times with EBC plus 0.5% NP-40, resuspended in 50 ml of 26Laemmli SDS ± PAGE sample buer and incubated at 958C for 10 min. The immunoprecipitated proteins were resolved on SDS ± PAGE and transferred to Immobilon-P for Western blot analysis.
Protein affinity chromatography using immobilized GSTRb or GSTRb209
Samples containing either cell extracts (500 ml, 0.5% NP40) or puri®ed bvUBF1 (2 mg) were tumbled for 2 h with 20 ml (*3 mg) of either puri®ed GSTRb or GSTRb209 bound to GSH-Sepharose beads, or GSH-Sepharose beads alone. The beads were washed three times with 300 ml of PBS containing 20% glycerol and 0.5% NP40. Alternatively, 2 ml of bvUBF1 (2 mg) puri®ed from Sf9 cells (Cavanaugh et al., 1995) , 180 ml of C/10 (20 mM HEPES, 100 mM KCl, 0.1 mM EDTA, 5 mM MgCl 2 (pH 7.9) containing 10% glycerol) plus 0.5% NP40 was tumbled for 2 h with 20 ml of either GSTRb or GSTRb209 bound to GSH-Sepharose beads, or GSHSepharose beads alone. In both cases bound proteins were eluted twice by incubating the beads for 10 min on ice with 25 ml of 50 mM glutathione. The eluted proteins were fractionated by SDS ± PAGE and transferred to Immobilon-P for Western blot analysis.
Protein affinity chromatography using TAF 1 48-FLAG beads Sf9 cells were infected with baculovirus expressing TAF 1 48-FLAG. After 4 days of infection the Sf9 cells were pelleted by centrifugation (1000 g, 5 min) and washed with 5 ml of icecold PBS. The washed pellet was resuspended in 400 ml of RIPPA buer (20 mM Tris, pH 8.0, 137 mM NaCl, 10% glycerol, 2 mM EDTA, 1% NP-40, 0.3% SDS, 0.4% Deoxycholate (DOC), 100 ml/ml aprotinin, 100 mM benzamidine, 10 mM leupeptin) and 3.5 ml of PBS containing 20% glycerol and protease inhibitors (benzamidine, aprotinin, leupeptin). The sample was tumbled with 600 ml of washed anti-FLAG anity gel beads (50% slurry: Kodak-ICI) for 2 h at 48C. After 2 h, the beads were pelleted by centrifugation, washed three times with 1 ml of PBS containing 20% glycerol, once with 1 ml of PBS containing 0.5 M NaCl and 20% glycerol, and then resuspended in 600 ml of PBS/20% glycerol.
Samples containing the appropriate recombinant proteins and peptides were made up to a ®nal volume of 300 ml with EBC buer and NP-40 to a ®nal concentration of 0.1%. The proteins and peptides used include: (i) full-length UBF1 (pVL1393UBF1, named for the original vector) which was expressed and puri®ed from Sf9 cells; (ii) GSTRb; (iii) E7 peptide (LQPGTTDLYCYEQLNDSS), which includes the functional consensus sequence LxCxE found in cellular and viral proteins that interact with the A/B pocket of Rb (Bignon et al., 1990; Cavanaugh et al., 1995) ; and (iv) E7* peptide (LQPGTTDLYCYQQLNDSS), which includes an inactive LxCxE sequence and can no longer bind to the A/B pocket of Rb (Bignon et al., 1990; Cavanaugh et al., 1995) . The samples were incubated for 2 h with 25 ml of TAF 1 48-FLAG beads. Following this, the beads were washed three times with 300 ml of EBC buer plus 0.1% NP-40. Proteins that bound to the TAF 1 48-FLAG resin were eluted by incubating the beads on ice with 30 ml of FLAG peptide (0.5 mg/ml) for 10 min. The elution was repeated, the eluted proteins were pooled, resolved by SDS ± PAGE, and transferred to Immobilon-P for Western blot analysis. The UBF used in these experiments was expressed in Sf9 cells and puri®ed from nuclear extracts through the DEAE-sephadex and heparin-agarose steps described previously .
Footprinting
DNase footprinting assays were carried out essentially as described previously . The conditions of the footprinting reactions were the same as those used for in vitro transcription. The UBF used in these assays was puri®ed as described previously and the GSTRb was puri®ed as described above.
Supershift assays
EMSA assays were carried out using puri®ed recombinant bvUBF1 and cruciform DNA essentially as described by Copenhaver et al. (1994) . When indicated, puri®ed recombinant GSTRb was added to the assays to determine the eect of Rb on the binding of UBF to cruciform DNA.
Transfections and CAT assays
NIH3T6 cells (0.1610 6 cells/plate) were co-transfected with various combinations of pSMECAT (a wild-type rDNA promoter reporter), pCDNA3UBF1 (a vector that drives the expression of rat UBF1) (Hannan et al., 1996b; 2000) , and varying concentrations of pCMVp130 (a vector that drives the expression of wild-type p130 kindly supplied by Dr Peter Whyte; Pertile et al., 1995) . pSMECAT-7 was used in place of pSMECAT in some experiments. pSMECAT-7 contains a G to A substitution at 77 in the rDNA promoter which inhibits transcription by RNA polymerase I (Xie et al., 1992) . Thus, pSMECAT-7 is a control for the possibility that CAT expression results from transcription by RNA polymerase II or RNA polymerase III.
The total amount of DNA used in transfections was kept constant (5 mg) by adding varying amounts of pCDNA3. pCMV-bGal (1 mg) was included as an internal standard for the eciency of transfection. Five hours after transfection using lipofectamine (Life Sciences), the culture medium was replaced with fresh DMEM containing 10% FBS. Twentyfour hours later the cells were harvested as described (Ausubel et al., 1993) , and frozen at 7808C until assayed for either chloramphenicol acetyltransferase (CAT) or bgalactosidase activity (Ausubel et al., 1993) . The results of the CAT assays were normalized with respect to b-galactosidase activity to correct for variations in the eciency of transfection. In general, the variation of b-galactosidase activity within an experiment was+10%.
